Global Drug Information Database

Columns

• drug_name: The common name of the drug.
• medical_condition: The medical condition for which the drug is prescribed or used.
• side_effects: A list of reported side effects associated with the drug.
• generic_name: The chemical name of the drug, distinct from its brand name.
• drug_classes: The classification of the drug based on its chemical structure, mechanism of action, or therapeutic use.
• brand_names: The commercial names under which the drug is marketed.
• activity: An indicator of recent site visitor interest relative to other medications in the list.
• rx_otc: Details whether the drug requires a prescription (Rx), is available over-the-counter (OTC), or can be either.
• pregnancy_category: A classification indicating the potential risk of the drug to a foetus during pregnancy (categories A, B, C, D, X, N).
  • A: Adequate and well-controlled studies show no risk to the foetus in the first trimester.
  • B: Animal studies show no foetal risk, but no adequate human studies exist.
  • C: Animal studies show adverse foetal effects; no adequate human studies, but potential benefits may warrant use.
  • D: Positive evidence of human foetal risk, but potential benefits may warrant use despite risks.
  • X: Studies show foetal abnormalities; risks clearly outweigh potential benefits in pregnant women.
  • N: FDA has not classified the drug.
• csa: Controlled Substances Act (CSA) Schedule, indicating the drug's potential for abuse and accepted medical use in the United States (M, U, N, 1, 2, 3, 4, 5).
  • M: Multiple possible schedules depending on dosage or strength.
  • U: Schedule is unknown.
  • N: Not subject to the Controlled Substances Act.
  • 1: High potential for abuse, no accepted medical use.
  • 2: High potential for abuse, accepted medical use with severe restrictions.
  • 3: Lower abuse potential than schedules 1 and 2, accepted medical use.
  • 4: Low abuse potential relative to schedule 3, accepted medical use.
  • 5: Low abuse potential relative to schedule 4, accepted medical use.
• alcohol: Indicates if the drug interacts with alcohol.
• rating: User-assigned effectiveness rating, typically on a scale of 1 to 10 (1 = not effective, 10 = most effective).

Distribution

Usage

• Pharmaceutical research: Analysing drug properties, side effects, and interactions.
• Healthcare applications: Developing tools for patients and professionals to access drug information.
• Public health studies: Investigating patterns of drug usage, side effect prevalence, and medication effectiveness.
• Educational purposes: Supporting studies in pharmacology, medicine, and public health.
• Data analytics: Building models for drug efficacy, safety monitoring, and market analysis.

Coverage

License

Who Can Use It

• Researchers in pharmacology, epidemiology, and public health.
• Healthcare professionals seeking quick reference for drug details, side effects, and regulatory statuses.
• Data scientists and analysts developing health-related applications or conducting market research.
• Academics and students for educational and research projects.
• Patients and the general public interested in understanding medications they use.

Dataset Name Suggestions

• Global Drug Information Database
• Pharmaceutical Drugs and Side Effects Data
• Medication Details and Patient Reviews
• Drug Efficacy and Safety Dataset
• Healthcare Drug Reference

Attributes